20/20 Biolabs, Inc. (AIDX)
Market Closed
16 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 57
-0.03
-4.1833%
$
3.36M Market Cap
- P/E Ratio
- Div Yield
729,312 Volume
- Eps
$ 0.6
Previous Close Want to track AIDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
20/20 Biolabs, Inc. (AIDX) Statistics
Valuation metrics
Market Cap 3.36M
Enterprise value 1.83M
Trailing P/E (ttm) -1.76
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) 4.15
Price/Book (mrq) 2.89
Enterprise Value/Revenue 1.4
Enterprise Value/EBITDA -0.53
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 3.07M
Average volume (90 days) 674.7K
Price summary
52-Week low 0.55
52-Week high 50
Beta -
50-Day moving average 1.21
200-Day moving average 2.42
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.21%
Operating margin -2.67%
Operational effectiveness
Return on assets -0.72%
Return on equity 1.12%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.17
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.55
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.55
Total debt (mrq) -
Total Debt/Equity (mrq) 0.24
Current ratio (mrq) 1.82%
Book value per share (mrq) 0.7
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
